01.04.2014 - The U.S. Supreme Court on Mar. 31 agreed to hear an appeal filed by Teva Pharmaceutical Industries in a patent fight over top-selling multiple sclerosis drug Copaxone. The move...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)